[1]韩丽萍)△,刘丽雅),孙晓慧),等.宫颈癌组织中FOXP3、PD-1及PD-L1蛋白的表达[J].郑州大学学报(医学版),2017,(01):83-88.[doi:10.13705/j.issn.1671-6825.2017.01.022]
 HAN Liping),LIU Liya),SUN Xiaohui),et al.Expression and correlation analysis of FOXP3, PD-1 and PD-L1 in the cervical cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(01):83-88.[doi:10.13705/j.issn.1671-6825.2017.01.022]
点击复制

宫颈癌组织中FOXP3、PD-1及PD-L1蛋白的表达()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年01期
页码:
83-88
栏目:
应用研究
出版日期:
2017-01-15

文章信息/Info

Title:
Expression and correlation analysis of FOXP3, PD-1 and PD-L1 in the cervical cancer
作者:
韩丽萍1)△刘丽雅12)孙晓慧3)李 元12)余海洋4)张庆庆12)
1)郑州大学第一附属医院妇产科 郑州 450052;
2)河南省高等学校临床重点学科开放实验室 郑州 450052;
3)安阳市肿瘤医院妇产科 河南安阳 455000;
4)郑州市中心医院妇产科 郑州 450007
Author(s):
HAN Liping1)LIU Liya12)SUN Xiaohui3)LI Yuan12)YU Haiyang4)ZHANG Qingqing12)
1)Department of Gynaecology,the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052;
2)Key-Disciplines Laboratory of Clinical-Medicine of Henan,Zhengzhou 450052;
3)Department of Gynaecology,Tumor Hospital of Anyang, Anyang, Henan 455000;
4)Department of Gynaecology,Zhengzhou Central Hospital Affiliated,Zhengzhou University, Zhengzhou 450007
关键词:
宫颈癌 PD-1 PD-L1 FOXP3
Keywords:
cervical cancer PD-1 PD-L1 FOXP3
分类号:
R711.74
DOI:
10.13705/j.issn.1671-6825.2017.01.022
摘要:
目的:研究宫颈癌组织中FOXP3、PD-1及PD-L1蛋白的表达情况及其与临床病理特征的关系。方法:采用免疫组织化学SP法检测64例宫颈癌组织、40例宫颈上皮内瘤样病变(CIN)组织、18例正常宫颈组织中PD-1、PD-L1、FOXP3蛋白的表达。结果:PD-1 、FOXP3蛋白主要表达于肿瘤浸润淋巴细胞(TIL),PD-L1 蛋白主要表达于宫颈癌细胞及TIL。正常宫颈组织不表达PD-1、PD-L1、FOXP3蛋白,宫颈癌组织中PD-1的表达显著高于CIN和正常宫颈组织(P<0.05); 宫颈癌组织中PD-1、PD-L1、FOXP3蛋白的表达与组织分化程度、FIGO分期有关(P<0.05),与患者年龄、肿瘤直径、HPV感染或分型无关(P>0.05)。宫颈癌组织中PD-L1与PD-1蛋白的表达呈正关联(rS=0.562,P<0.001)。宫颈癌组织中FOXP3与PD-1 、PD-L1蛋白的表达无关联(rS =0.218和0.257,P>0.05)。结论:人子宫颈癌组织高表达PD-1、PD-L1、FOXP3蛋白,且与肿瘤的发生发展、浸润密切相关。
Abstract:
Aim: To explore the expression of PD-1, PD-L1 and FOXP3 proteins in human normal cervical tissues, cervical intraepithelial neoplasia,cervical cancer, and their relationship with clinical features.Methods: Immuno-histochemical SP method was used to detect the expressions of PD-1, PD-L1, FOXP3 in tissue obtained from 64 cases of cervical cancer, 40 cases of cervical intraepithelial neoplasia(CIN),18 cases of normal cervical tissue.Results: FOXP3, PD-1 was mainly expressed on TIL, PD-L1was mainly expressed in cervical cancer cells and TIL. There were no expression of PD-1, PD-L1,FOXP3 in normal cervical tissues. The positive expression rate of PD-1, PD-L1, FOXP3 in cervical cancer tissues was significantly higher than that in cervical CIN tissues, and the difference was statistically significant(P<0.05); The expression of PD-1, PD-L1 and FOXP3 in cervical carcinoma was related to the degree of differentiation,FIGO stage, the difference being statistically significant(P<0.05), and without any correlation with age, tumor size, HPV infection(P>0.05). The expression of PD-L1 and PD-1 in cervical carcinoma cells was positively correlated(rS=0.562,P<0.001). The expression of FOXP3 and PD-1,PD-L1 in cervical cancer tissue had no significant correlation(rS=0.218,0.257,P>0.05).Conclusion: The expression of PD-L1 and PD-1 in human cervical cancer tissues is increased, which is closely related to the occurrence, development, infiltration and metastasis of the tumor.

参考文献/References:

[1] JEMAL A,BRAY F,CENTER MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69
[2] JAYSHREE RS,SREENIVAS A,TESSY M,et al.Cell intrinsic extrinsic factors in cervical carcinogenesis[J].Indian J Med Res,2009,130(3):286
[3] SHI F,SHI M,ZENG Z,et al.PD-1 and PD-L1 upregulation promotes CD8(+)T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients[J].Int J Cancer,2011,128(4):887
[4] GERSHON RK.A disquisition on suppressor T cells[J].Transplant Rev,1975,26:170
[5] VAN DER BURG SH,PIERSMA SJ,DE JONG A,et al.Association of cervical cancer with the presence of CD4+regulatory T cells specific for human papillomavirus antigens[J].Proc Natl Acad Sci U S A,2007,104(29):12087
[6] KEIR ME,BUTTE MJ,FREEMAN GJ,et al.PD-1 and its ligands in tolerance and immunity[J].Annu Rev Immunol,2008,26:677
[7] DORFMAN DM,BROWN JA,SHAHSAFAEI A,et al.Programmed death-1(PD-1)is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma[J].Am J Surg Pathol,2006,30(7):802
[8] OHAEGBULAM KC,ASSAL A,LAZAR-MOLNAR E,et al.Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway[J].Trends Mol Med,2015,21(1):24
[9] YAMAZAKI T,AKIBA H,IWAI H,et al.Expression of programmed death 1 ligands by murine T cells and APC[J].J Immunol,2002,169(10):5538
[10]LI B,VAN ROEY M,WANG CY,et al.Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors[J].Clin Cancer Res,2009,15(5):1623
[11]DULOS J,CARVEN GJ,VAN BOXTEL SJ,et al.PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer[J].J Immunother,2012,35(2):169
[12]KARIM Rezaul,JORDANOVA S,PIERSMA J,et al.Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma[J].Clin Cancer Res,2009,15(20):6341
[13]马薇,罗殿中,陈源,等.PD-L1和PD-1在非小细胞肺癌中的表达及其临床意义[J].实用医学杂志,2011,27(9):1551
[14]吴圣,邵婧怡,王芳,等.PD-L1和 PD-1在胃癌组织中的表达及其临床意义[J].安徽医科大学学报,2015(6):821
[15]刘书漫,孟青,张钦宪,等.B7-H1及其受体PD-1在胃癌组织中的表达与意义[J].中华肿瘤杂志,2008,30(3):192
[16]WHITESIDE TL.Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?[J].Cancer Immunol Immunother,2014,63(1):67
[17]HORI S,NOMURA T,SAKAGUCHI S.Control of regulatory T cell development by the transcription factor Foxp3[J].Science,2003,299(569):1057
[18]JIN Yonglong,GUAN Songlei,LIU Linlin,et al.Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer[J].Asia Pac J Clin Oncol,2015,11(4):e37
[19]YE L,GUAN S,ZHANG C,et al.Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma[J].Tumour Biol,2013,34(3):1873
[20]CUNHA Leite,MORARI Cristina,NONOGAKI Suely,et al.Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas[J].Clinics(Sao Paulo),2012,67(5):483
[21]SCOTT ME,MA Y,KUZMICH L,et al.Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3[J].Int J Cancer,2009,124(6):1379

相似文献/References:

[1]樊素珍△,苑中甫.宫颈癌组织中AnnexinA2和Ki67蛋白的表达[J].郑州大学学报(医学版),2010,(01):81.
 FAN Suzhen,YUAN Zhongfu.Expression of Annexin A2 and Ki67 in cervical cancer tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(01):81.
[2]郭君丽△,孔红霞.宫颈鳞状细胞癌组织中血管紧张素Ⅱ及其受体1和碱性成纤维细胞生长因子的表达[J].郑州大学学报(医学版),2009,(02):362.
 GUO Junli,KONG Hongxia.Expression of AngⅡ,AT1R and bFGF in squamous cervical carcinoma tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(01):362.
[3]杨丽,董阅芝.青年宫颈癌患者术后实施配偶健康教育效果观察[J].郑州大学学报(医学版),2009,(04):921.
[4]岳青芬,刘格琳,侯青霞.中晚期宫颈癌215例综合治疗体会[J].郑州大学学报(医学版),2009,(03):676.
[5]南燕,李红雨#,许雅娟.宫颈癌组织中TSPAN1与Ki67蛋白的表达[J].郑州大学学报(医学版),2010,(03):469.
 NAN Yan,LI Hongyu,XU Yajuan.Expression of TSPAN1 and Ki67 proteins in cervical carcinoma tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(01):469.
[6]马洪涛,秦巧红,李红雨,等.浸润性宫颈癌119例综合治疗体会[J].郑州大学学报(医学版),2010,(05):849.
[7]张占薪),罗大虎),张占化),等.局部晚期宫颈癌新辅助化疗39例[J].郑州大学学报(医学版),2010,(04):681.
 [J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(01):681.
[8]程淑霞,成慧君,王莉.宫颈癌治疗后未控及复发转移121例分析[J].郑州大学学报(医学版),2010,(06):1044.
[9]叶自青,张小安#,赵鑫,等. MRI常规平扫结合弥散加权成像对宫颈癌的诊断价值[J].郑州大学学报(医学版),2011,(03):464.
 [J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(01):464.
[10]武海英,史惠蓉#.不同宫颈病变组织中CMYC基因与P16蛋白的表达[J].郑州大学学报(医学版),2011,(05):739.
 WU Haiying,SHI Huirong.Expressions of CMYC and P16 in different cervical lesions[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(01):739.

备注/Memo

备注/Memo:
△女,1969年8月生,博士,教授,研究方向:妇科肿瘤与妇科内分泌,E-mail:hanliping0825@163.com
更新日期/Last Update: 2017-01-20